EPA & DHA Omega-3 PUFA Market - Forecast(2024 - 2030)

Report Code: FBR 0465 Report Format: PDF + Excel

EPA & DHA Omega-3 PUFA Market Overview

EPA  & DHA Omega-3 PUFA Market size is estimated to reach $5.28 billion by 2027, growing at a CAGR of 7.81% during the forecast period 2022-2027. Omega-3 fatty acids also termed Omega-3 oils, ?-3 fatty acids, or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) featured by the existence of a double bond, three atoms away from the terminal methyl group in their chemical structure. They are extensively distributed in nature, being significant components of animal lipid metabolism, and they play a vital role in the human diet and in human physiology. The three kinds of omega-3 fatty acids included in human physiology are ?-linolenic acid (ALA), discovered in plant oils, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), both typically discovered in oils of marine fish. Currently, the oilseed crop has been genetically engineered to generate the long-chain omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) at levels identical to that discovered in fish oil, to offer a more sustainable source of these compounds than is prevailing from wild fish capture. Investigations including omega-3 fatty acid supplementation and pregnancy have indicated everyday intake of eicosapentaenoic acid and docosahexaenoic acid with either fish oil with DHA (0.5 g) and EPA (0.15 g) or with methyltetrahydrofolic acid (400 ?g), both, or placebo, from gestation week 22.

The surging inclusion of eicosapentaenoic acid and docosahexaenoic acid in the everyday diet of consumers is set to drive the EPA & DHA Omega-3 PUFA Market. The soaring applications of eicosapentaenoic acid and docosahexaenoic acid in food, dietary supplements, and clinical nutrition are set to propel the growth of the EPA & DHA Omega-3 PUFA Market during the forecast period 2022-2027. This represents the EPA & DHA Omega-3 PUFA Industry Outlook.

Report Coverage

The report: EPA & DHA Omega-3 PUFA Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the EPA & DHA Omega-3 PUFA Market.

By Type: Docosahexaenoic acid (DHA), Eicosapentanoic acid (EPA), Alpha-Linolenic Acid (ALA), Others.
By Source: Marine, Plant.
By Application: Food And Beverages (Functional Foods & Beverages, Infant Formula), Dietary Supplements, Pharmaceuticals, Animal Nutrition, Others.
By Geography: North America (U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America EPA & DHA Omega-3 PUFA Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the surging awareness regarding eicosapentaenoic acid and docosahexaenoic acid and the subsequent strong demand from health-conscious consumers in the North American region.
  • EPA & DHA Omega-3 PUFA Market growth are being driven by the soaring demand for polyunsaturated fatty acids including eicosapentaenoic acid and docosahexaenoic acid in functional foods and surging concerns for healthcare. However, the heightening cost of fish oil is one of the major factors hampering the growth of the EPA & DHA Omega-3 PUFA Market. 
  • EPA & DHA Omega-3 PUFA Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the EPA & DHA Omega-3 PUFA Market report

EPA & DHA Omega-3 PUFA Market: Market Share (%) by Region, 2021

For More Details on This Report - Request for Sample

EPA & DHA Omega-3 PUFA Market Segment Analysis – By Type

The EPA & DHA Omega-3 PUFA Market based on type can be further segmented into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-Linolenic Acid (ALA), and Others. The Eicosapentaenoic acid (EPA) Segment held the largest market share in 2021. This growth is owing to the heightening awareness regarding the health advantages of Eicosapentaenoic acid. The prenatal everyday supplementation of EPA has been discovered to provide an improved safeguard against allergic results in infants and children up to school-going age. The proliferating application of Eicosapentaenoic acid n animal feed and clinical nutrition is further propelling the growth of the Eicosapentaenoic acid (EPA) segment.

Furthermore, the Docosahexaenoic acid (DHA) segment is estimated to grow with the fastest CAGR of 8.4% during the forecast period 2022-2027 owing to the vital role of Docosahexaenoic acid for brain development at the time of pregnancy and early childhood and also its protective action against ailments like arthritis.

EPA & DHA Omega-3 PUFA Market Segment Analysis – By Application

The EPA & DHA Omega-3 PUFA Market based on the application can be further segmented into Food And Beverages, Dietary Supplements, Pharmaceuticals, Animal Nutrition, and others. The Dietary Supplements Segment held the largest market share in 2021. This growth is owing to the soaring accessibility of dietary supplements including Eicosapentaenoic acid and Docosahexaenoic acid worldwide. Eicosapentaenoic acid is utilized in integration with docosahexaenoic acid (DHA) in fish oil preparations for an assortment of conditions, inclusive of averting and reversing heart disease. The surging awareness of the health benefits of Eicosapentaenoic acid and Docosahexaenoic acid is further propelling the growth of this segment.

Furthermore, the Food And Beverages segment is estimated to grow with the fastest CAGR of 8.6% during the forecast period 2022-2027 owing to the surging application of Docosahexaenoic acid in infant formula in conjunction with the proliferating birth rates and purchasing power of parents worldwide.

EPA & DHA Omega-3 PUFA Market Segment Analysis – By Geography

The EPA & DHA Omega-3 PUFA Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the rest of the World. North America (EPA & DHA Omega-3 PUFA Market) held the largest share with 37% of the overall market in 2021. The growth of this region is owing to the soaring demand of health-conscious consumers attributed to their altered lifestyles in the region. The surging benefits of Eicosapentaenoic acid and Docosahexaenoic acid on health like averting cardiovascular diseases by minimizing triglyceride levels and minimizing obesity is further driving the growth of EPA & DHA Omega-3 PUFA Market in this region. The existence of key players like Zymes LLC in New Jersey, the U.S. in the region is further propelling the growth of the EPA & DHA Omega-3 PUFA Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the existence of principal markets for omega 3 constituents like China, Japan, and Australia in the Asia-Pacific region. The proliferating demand for Docosahexaenoic acid-based constituents for infant nutritional formulae is further fuelling the progress of the EPA & DHA Omega-3 PUFA Market in the Asia-Pacific region.

EPA & DHA Omega-3 PUFA Market Drivers

Soaring Benefits Of Eicosapentaenoic Acid (EPA) Are Projected To Drive The Growth Of EPA & DHA Omega-3 PUFA Market:

Eicosapentaenoic acid (EHA) brings about certain very powerful health benefits. Investigations indicate that the eicosapentaenoic acid in fish oil supplements can assist in the reduction of numerous hazard determinants pertaining to cardiovascular disease, inclusive of arterial calcification, high blood pressure, and raised triglycerides. Introductory research recommends that EPA assists in averting the build-up of calcium residues in arteries. It minimizes the symptoms of depression. It alleviates the symptoms of menopause. It minimizes symptoms and delays the advancement of rheumatoid arthritis. The soaring benefits of Eicosapentaenoic Acid (EPA) are therefore fuelling the growth of the EPA & DHA Omega-3 PUFA Market during the forecast period 2022-2027.

Surging Applications Of Docosahexaenoic Acid (DHA) Are Expected to Boost the Demand of EPA & DHA Omega-3 PUFA Market:

Docosahexaenoic Acid (DHA) is principally discovered in seafood like fish, shellfish, and algae. Docosahexaenoic Acid is the richest omega-3 in the brain and plays a crucial role in its growth and function. It is excessively significant for brain tissue development and function, specifically at the time of growth and infancy. It is required to collect in the central nervous system for the eyes and brain to establish ordinarily. DHA consumption at the time of the third trimester of pregnancy decides the baby’s levels, with the highest collection happening in the brain at the time of the earliest few months of life. DHA is principally discovered in the gray matter of the brain, and the frontal lobes are specifically relying on it at the time of growth. The surging applications of Docosahexaenoic Acid (DHA) are therefore driving the growth of the EPA & DHA Omega-3 PUFA Market during the forecast period 2022-2027.

EPA & DHA Omega-3 PUFA Market Challenges

Dearth Of Clarity On The Intake Of EPA & DHA Omega-3 PUFA and Certain Regulations are Hampering the Growth Of The EPA & DHA Omega-3 PUFA Market:

The Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) Omega-3 PUFA Market comprising fortified nutritional supplements and food and beverages is encountering considerable blocks in the absence of official recommended doses. Regardless of the exhaustive scientific research performed by governments and non-governmental organizations (NGOs), a particular standard dose of EPA & DHA Omega-3 PUFA for everyday intake is not clear and has therefore not been established. Furthermore, as per the recommendations of the International Expert Group (IEG), the content of EPA should not be greater than the content of DHA which is building a barrier for key players who are amenable to launching EPA-based infant formula products. These issues are hampering the growth of the EPA & DHA Omega-3 PUFA Market.

EPA & DHA Omega-3 PUFA Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the EPA & DHA Omega-3 PUFA Market. Key companies of this market are:

  1. Zymes LLC
  2. Barleans Organic Oils
  3. Denomega Nutritional Oils
  4. Copeinca ASA
  5. Martek Biosciences Corporation
  6. Omega Protein Corp
  7. Horizon Organic
  8. Golden Omega
  9. Pharma Marine USA LLC
  10. Pesquera Pacific Star S.A.

Recent Developments

  • In December 2021, Horizon Organic who declared this summer that it would halt the purchase of milk from 89 organic dairy farms in the Northeast next August has proffered to expand those contracts for another six months. Danone, the parent firm of Horizon Organic, alerted officials in Vermont, Maine, and New York this week. The 28 farms in Vermont and a total of 61 in Maine, New Hampshire, and New York were anticipated to lose their contracts at the end of August next year when Danone would halt the purchase of milk in the region.
  • In October 2021, GC Rieber VivoMega declared the introduction of the VivoMega soft-gel sampling program. Accessible to North American customers, the firm pronounces that the samples will demonstrate how its omega-3 constituents can be utilized to aim distinct health advantages. The constituent is targeted to permit better taste and smell, and with omega-3 oils, there is a minimum sensory experience, inclusive of minimization in fishy aftertaste or belches.
  • In March 2021, Horizon Organic® Growing Years™ teamed with pediatricians to extend the product line. With novel partners in tow, the natural dairy brand doubles down on development in this key sector. Horizon Organic® declared the extension of its Growing Years™ line to presently involve low-fat yogurt pouches, cultured dairy smoothies, reduced-fat milk half gallons, and single-serve whole milk boxes accessible currently at grocery stores countrywide.

Related Reports-

Omega-3 PUFA Market – Forecast (2021 - 2026)
Report Code: FBR 78258

Omega 3 And 6 Market – Forecast (2021 - 2026)
Report Code: FBR 0243

For more Food and Beverage Market reports, please click here

1. EPA & DHA Omega-3 PUFA Market Overview
    1.1 Definitions and Scope
2. EPA & DHA Omega-3 PUFA Market - Executive Summary
3. EPA & DHA Omega-3 PUFA Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. EPA & DHA Omega-3 PUFA Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. EPA & DHA Omega-3 PUFA Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. EPA & DHA Omega-3 PUFA Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. EPA & DHA Omega-3 PUFA Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. EPA & DHA Omega-3 PUFA Market - By Type (Market Size –$Million/$Billion) 
    8.1 Docosahexanoic acid (DHA)
    8.2 Eicosapentanoic acid (EPA)
    8.3 Alpha-Linolenic Acid (ALA)
    8.4 Others
9. EPA & DHA Omega-3 PUFA Market - By Source (Market Size –$Million/$Billion) 
    9.1 Marine
    9.2 Plant
10. EPA & DHA Omega-3 PUFA Market – By Application (Market Size –$Million/$Billion) 
    10.1 Food And Beverages
        10.1.1. Functional Foods & Beverages
        10.1.2. Infant Formula
    10.2 Dietary Supplements
    10.3 Pharmaceuticals
    10.4 Animal Nutrition
    10.5 Others
11. EPA & DHA Omega-3 PUFA Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest Of The World
        11.5.1 Middle East
        11.5.2 Africa
12. EPA & DHA Omega-3 PUFA Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. EPA & DHA Omega-3 PUFA Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. EPA & DHA Omega-3 PUFA Market– Key Company List by Country Premium (Premium)
15. EPA & DHA Omega-3 PUFA Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"